# Neuronetics (STIM) Stock Price, News & Analysis
Canonical URL: https://biopharmsignal.com/company/STIM
## Company Profile
- Ticker: STIM
- Exchange: NASDAQ
- Sector: Biopharma
- Location: United States
- Tags: MedTech
## Stock Data
- Close: 2.35 USD
- Market cap: 108557030.4 USD
- Last updated: 2026-08-05
## Business Overview
### Neurohealth Technology and Care Delivery
Neuronetics is a commercial-stage medical technology and healthcare company focused on non-invasive treatment of neuropsychiatric disorders. It combines a proprietary treatment system with a national network of clinics that directly delivers therapy.
### NeuroStar Advanced Therapy
NeuroStar uses transcranial magnetic stimulation to treat major depressive disorder without surgery or systemic medication. The platform is supported by a large clinical dataset and is sold to healthcare providers together with recurring treatment-session consumables and services.
### Greenbrook Clinic Network
Through Greenbrook treatment centers, Neuronetics directly provides NeuroStar therapy and SPRAVATO for treatment-resistant depression. The integrated model gives the company exposure to both medical-device utilization and the economics of operating behavioral-health treatment sites.
## Why The Stock Is Moving

As of Aug 5, 2026, STIM closed up 2.17% at $2.35. No new same-company headline was identified in the current news window.

## Future Catalysts

- Neuronetics’ catalysts are neurostimulation adoption, payer coverage, and continued growth in mental-health treatment use. The company needs broader procedure adoption to keep the story moving.

## Recent News
- 2026-08-03 12:00 EST — [Neuronetics and Jorey Chernett Announce Shared Vision](https://biopharmsignal.com/news/STIM/neuronetics-and-jorey-chernett-announce-shared-vision-df32000a) — Source: Neuronetics
- 2026-07-31 21:00 EST — [Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)](https://biopharmsignal.com/news/STIM/neuronetics-reports-inducement-grant-under-nasdaq-listing-rule-5635-c-4-a098f270) — Source: Neuronetics
- 2026-07-28 12:32 EST — [Greenbrook Opens National Center of Excellence for Advanced Interventional Psychiatry in Rockville, Maryland](https://biopharmsignal.com/news/STIM/greenbrook-opens-national-center-of-excellence-for-advanced-interventional-psych-02bd5807) — Source: Neuronetics
- 2026-07-28 12:30 EST — [Neuronetics to Report Second Quarter 2026 Financial and Operating Results and Host Conference Call](https://biopharmsignal.com/news/STIM/neuronetics-to-report-second-quarter-2026-financial-and-operating-results-and-ho-e0688305) — Source: Neuronetics
- 2026-07-20 20:05 EST — [Neuronetics Appoints Nir Naor Chief Financial Officer; Announces Additional Management Changes](https://biopharmsignal.com/news/STIM/neuronetics-appoints-nir-naor-chief-financial-officer-announces-additional-manag-6e471c15) — Source: Neuronetics